Company Disclosure
Acutaas Chemicals Limited (Scrip Code: 543349, NSE Symbol: ACUTAAS) has made a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Nature of Event
Management promotion and designation change of Mr. Anurag Shukla to Senior Management Personnel.
Key Details of Promotion
The Nomination and Remuneration Committee of the Company, at its meeting held on July 2, 2026, approved the promotion and designation of Mr. Anurag Shukla as "General Manager Operations & Unit Head - Ankleshwar." This designation is effective from July 2, 2026.
Background of Mr. Anurag Shukla
Mr. Shukla has been associated with the Company since September 1, 2021, when he joined as Senior Manager. He was later promoted to Assistant General Manager - Operations before this current promotion.
He holds a Master of Science (Organic Chemistry) and has over 21 years of extensive experience in pharmaceutical API and intermediates manufacturing. His expertise includes plant operations, project management, production, quality systems, and regulatory compliances. He has significant experience in setting up manufacturing facilities, leading regulatory audits by global agencies, driving operational excellence, capacity enhancement, and cost optimization.
Prior to joining Acutaas Chemicals, Mr. Shukla held leadership and managerial positions with several reputed pharmaceutical companies including:
- Alembic Pharmaceuticals Limited
- IPCA Laboratories Limited
- Dishman Pharmaceuticals & Chemicals Limited
- Kalki Healthcare Private Limited
- Avitech Nutrition Private Limited
New Responsibilities
In his new role as General Manager Operations & Unit Head of Ankleshwar facility, Mr. Shukla will be responsible for overseeing the overall operations of the Company's Ankleshwar manufacturing Facility.